Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

New treatments are needed for non-scarring alopecia due to current limitations.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Herbal remedies may help with hair loss but need more research.

Red pigmented rice, like Sang-Yod rice, could help promote hair growth and prevent hair loss.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Thread-embedding therapy helped hair grow back in mice and might do the same in humans.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Lower finasteride doses had more side effects; dutasteride caused back pain; more research needed on post-finasteride syndrome.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Electrolysis is the only FDA-recognized permanent hair removal method.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Lasers and light treatments are now the most common ways to remove hair.